Neuroblastoma

5 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.

Broader: Neoplasms, Neoplasms, Germ Cell and Embryonal, Neuroectodermal Tumors, Primitive

Narrower: Ganglioneuroblastoma 2

Treatments and conditions

Neuroblastoma
Treatment and conditionWhere it standsTrials
Autologous hALK.CAR T cells for neuroblastomaPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
autologous NK cell plus GD2 antibody for neuroblastomaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Chemotherapy + MAPK inhibitors + ARSENIC TRIOXIDE for neuroblastomaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Magnetic Resonance Imaging + Biopsy Procedure + Bone Marrow Aspiration + Bone Marrow Biopsy + Clinical Observation + Computed Tomography + Ultrasound + ETOPOSIDE + Doxorubicin hydrochloride + Cyclophosphamide + Carboplatin for ganglioneuroblastomaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Magnetic Resonance Imaging + Clinical Observation + Computed Tomography + Ultrasound for ganglioneuroblastomaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1

Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.